Cosmeceuticals: myths and misconceptions

Clinics in Dermatology

Volumn 27, Issue 5, 2009, Pages 446-452

  Newburger, Amy E ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; NON PRESCRIPTION DRUG; RETINOIC ACID; TAZAROTENE;

ARTICLE; CONSUMER; FOOD AND DRUG ADMINISTRATION; LEGAL ASPECT; MARKETING; PHYSICIAN; PRIORITY JOURNAL; SAFETY;

ADMINISTRATION, CUTANEOUS; CONSUMER PRODUCT SAFETY; COSMETICS; DERMATOLOGIC AGENTS; DRUG APPROVAL; DRUG PACKAGING; DRUG TOXICITY; FEMALE; HUMANS; MALE; PATIENT EDUCATION AS TOPIC; SKIN ABSORPTION; SKIN CARE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 68749083912     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.05.008     Document Type: Article

References (39)

1. Prestige beauty industry reaches record $8 billion high. NPD press release. April 13, 2006. Available at:. www.NPD.com/press/releases/press_060413.html Accessed January 21, 2007
2. Reed R. The definition of "cosmeceutical". J Soc Cosmet Chem 13 (1962) 103-106
3. Riordan T. Inventing beauty (2004), Broadway Books, New York 19-24
4. Swann J. History of the FDA. In: Kurian G. (Ed). A historical guide to the US government (1998), Oxford University Press, New York
5. Federal Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. Sec. 301 et seq.
6. Milestones in U.S. food and drug law history. FDA Web site. Available at:. www.fda.gov/AboutFDA/WhatWeDo/History/Milestones/ucm128305.htm Accessed June 16, 2009
7. Federal Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. §379e.
8. Fair Packaging and Labeling Act (FPLA), 15 U.S.C. Sec. 1451 et seq. FDA Web site. Available at:. www.fda.gov/RegulatoryInformation/Legislation/ucm148722.htm Accessed June 16, 2009
9. Federal Food, Drug, and Cosmetic Act (FDCA), a. 21 U.S.C. §321(g); b. 21 U.S.C. §201(g)(1)(c); c. 21 U.S.C. §321(i).
10. Code of Federal Regulations. 21 C.F.R. §740.1.
11. a. Schmidt A. food drug and cosmetic products, warning statements. Federal Register, 40(42):8912-8929 (1975); b. 21 C.F.R. §740.10.
12. Federal Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. §361.
13. Federal Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. §362. Cosmetic Ingredient Review. Available at:. www.cir-safety.org Accessed June 16, 2009
14. Cruelty free-not tested on animals. FDA Web site. Available at:. www.fda.gov/cosmetics/CosmeticLabelingLabelClaims/LabelClaimsandExpirati onDating/ucm2005202.htm Accessed June 16, 2009
15. Code of Federal Regulations. 21 C.F.R. §250.250; 21 C.F.R. §§700.11-700.35.
16. Berdick M. Coping with the color additive regulations. In: Estrin N. (Ed). The cosmetic industry, scientific and regulatory foundations (1984), Marcel Dekker Inc., New York (NY) 385-414
17. FDA. Tattoos and permanent makeup. Available at:. www.fda.gov/Cosmetics/ProductandIngredientSafety/ProductInformation/ucm1 08530.htm Accessed: June 16, 2009
18. Fair Packaging and Labeling Act (FPLA), 15 U.S.C. §1454(c)(3); 21 C.F.R. §701.3.
19. Federal Trade Commission Act, 15 U.S.C. §§45 and 55.
20. Federal Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. §362(a-(f)).
21. 21 C.F.R. §§710-730.
22. Milstein S., Halper A., and Katz L. Regulatory requirements for the marketing of cosmetics in the United States. In: Paye M., Barel A., and Maibach H. (Eds). Handbook of cosmetic science and technology (2006), CRC Press, New York 838-839
23. 21 C.F.R. §§7.40-7.59.
24. Federal Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. §§331-334.
25. Kurtzweil, Paula. Hair relaxers destroyed after consumers complain - products sold by World Rio Corp. FDA Consumer Magazine March 1994
26. Meadows M. Heading off hair care disasters. FDA Consumer Magazine 2001;35. Available at: vm.cfsan.fda.gov/~dms/fdahdye.html. Accessed June 16, 2009.
27. FDA News: approximately $2 million of potentially harmful "cosmetic" eye product seized. Available at:. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109028.htm Accessed June 16, 2009
28. Greff J. Regulation of cosmetics that are also drugs. Food Drug Law J 51 (1996) 243-272
29. Jacobellis V. Ohio. 378 U.S. 184, 197. 1964.
30. Drugs approved by the FDA. Available at:. www.centerwatch.com/patient/drugs/dru31.html Accessed June 16, 2009
31. DiMasi J., Hansen R., and Grabowski H. The price of innovation: new estimates of drug development costs. J Health Econ 22 (2003) 151-185
32. FDA authority over cosmetics. FDA Web site. Available at:. www.cfsan.fda.gov/~dms/cos-206.html Accessed June 16, 2009
33. Paye M., and Barel A. Introduction to the "proof of claims". In: Paye M., Barel A., and Maibach H. (Eds). Handbook of cosmetic science and technology (2006), CRC Press, New York 880-886
34. Wentz R. Substantiating skin care cosmetic claims. Soap Cosmet Chem Spec 36-42 (1986) 54-56
35. Hypoallergenic cosmetics. FDA Web site. Available at:. www.fda.gov/Cosmetics/CosmeticLabelingLabelClaims/LabelClaimsandExpirati onDating/ucm2005203.htm Accessed June 16, 2009
36. Weichers J. Mind over matter: cosmetic claim substantiation issues facing the future. Cosmet Toilet 120 (2005) 57-64
37. Foulke J. Cosmetic ingredients: understanding the puffery. FDA Consumer Magazine, May 1992.
38. FTC Policy Statement on Deception, Appended to Cliffdale Associates, Ind. 103 F.T.C. 110, 174(1984). Available at: www.ftc.gov/bcp/policystmt/ad-decept.htm. Accessed June 16, 2009.
39. Smithles R. Substantiating performance claims. Cosmet Toilet 99 (1984) 79-84